BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Former Millennium ...
Glucksmann succeeds current Sensorium CEO and Co-Founder Dick Simon, who will transition to an advisory role and continue to serve on the Board of Directors The company announces a $3 million National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results